Virosomes

Journal of Antivirals & Antiretroviral is one of the top and best leading journals in the field of virology which publishes novel research articles on deadly viruses such as HIV. The articles after rigorous peer-review process with at least 2 expert reviewers, the article will be on to open access flow. Journal of Antivirals & Antiretroviral is an interesting field involved in developing agents that kills dangerous virus (or) Invents agents that suppresses its ability to replicate, hence, inhibits its capability to multiply and reproduce. A virosome is a drug or vaccine delivery mechanism consisting of unilamellar phospholipid membrane it may be mono- or bi-layered. Vesicle incorporating virus derived proteins to allow the virosomes to fuse with target cells. Virosomes are not able to replicate but are pure fusion-active vesicles. The development of safe and effective models for the delivery of any prophylactic or therapeutic agent remains an uphill task for pharmaceutical formulation developers. Drug molecules, nucleic acids, carbohydrates, proteins and a variety of other biological and chemical entities are used for attaining pharmacological benefits. However, the major challenge remains in the delivery of these agents to the specific site of action in a time-efficient manner. Among the many drug delivery systems developed, the nano scale technology of virosomes tends to present an established system of delivering the therapeutic agents to the site of pharmacological action. Virosomes are lipid bilayer, unilamellar structures that present viral protein on their surface. They are safe, biocompatible and biodegradable structures that can achieve ideal pharmacological profile once administered into the body. Tissue targeting, immune activation and potentiation are the chief advantages that make them efficient prophylactic and therapeutic agents. The review presents the biopharmaceutical applications of virosomes and the immunological and pharmaceutical considerations that make them efficient agents for targeting spatiotemporal parameters in the body. OMICS Group is the best open access publishers with expert editors/contributors and renowned scientists. Both editors and reviewers actively participate in the peer-review process and help in completing the review process within 21 days. Apart from this OMICS Group organizes more than 3000+ International Scientific Conferences.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on September, 2024